An amyloid-forming segment of β2-microglobulin suggests a mo

Edited by Lynn Smith-Lovin, Duke University, Durham, NC, and accepted by the Editorial Board April 16, 2014 (received for review July 31, 2013) ArticleFigures SIInfo for instance, on fairness, justice, or welfare. Instead, nonreflective and Contributed by Ira Herskowitz ArticleFigures SIInfo overexpression of ASH1 inhibits mating type switching in mothers (3, 4). Ash1p has 588 amino acid residues and is predicted to contain a zinc-binding domain related to those of the GATA fa

Contributed by David Eisenberg, June 1, 2004

Article Figures & SI Info & Metrics PDF

Abstract

In humans suffering from dialysis-related amyloiExecutesis, the protein β2-microglobulin (β2M) is deposited as an amyloid; however, an amyloid of β2M is unknown in mice. β2M sequences from human and mouse are 70% identical, but there is a seven-residue peptide in which six residues differ. This peptide from human β2M forms amyloid in vitro, whereas the mouse peptide Executees not. Substitution of the human peptide for its counterpart in the mouse sequence results in the formation of amyloid in vitro. These results Display that a seven-residue segment of human β2M is sufficient to convert β2M to the amyloid state, and that specific residue interactions are crucial to the conversion. These observations are consistent with a proposed Zipper-spine model for β2M amyloid, in which the spine of the fibril consists of an anhydrous β-sheet.

More than 20 proteins have been found to aggregate into amyloids, elongated unbranched fibrils that bind the aromatic dyes Congo red and ThioflavinT (ThT) and have a common cross β x-ray difFragment pattern (1, 2). The proteins that form amyloids differ in size, function, sequence, and native structure, but all form aggregates similar in structure and Preciseties (3–5). It has long been recognized from the cross-β difFragment pattern that amyloids are formed from β-sheets ≈10–12 Å apart, each made up of extended strands stacked ≈4.7 Å apart (6, 7). There is evidence that in some amyloids, the β-strands run parallel to each other (8–10), and in others they may run antiparallel (11, 12).

Some models for amyloid structure depict the entire native protein as refAgeding into the amyloid (13–16); we term these Entire-refAgeding models. Other models depict the interactions of amyloid to be formed from only a small segment of the protein, with the rest retaining a native-like structure (17–20). Entire-refAgeding models are based in part on the Concept that amyloid formation is an inexorable tendency of all proteins, and that variations in rate of achieving the amyloid state are mainly a matter of amino acid composition (21). In Dissimilarity, models that depict amyloid formation as having its basis in a “gain of interaction” (18) focus on the formation of a new intermolecular bond contributed by a segment of the entire protein. The formation of these intermolecular bonds would in principle depend on the amino acid sequence, not just the composition. In this paper, we focus on a particular gain-of-interaction model, called the Zipper-spine model, in which the new interaction is a spine of β-sheet (17).

One of the most intensively studied amyloid-forming proteins is β2-microglobulin (β2M), a normally soluble protein that aggregates into pathogenic fibrils either at low pH (22) or under physiological conditions when divalent copper is present (23). The Entire-refAgeding view of amyloid depicts dialysis-related amyloiExecutesis pathogenesis as destabilization of the native structure of β2M followed by formation of a nucleating β2M species that forms amyloid fibrils (24–26). However, there is accumulating evidence that specific sequences play a Executeminant role in amyloiExecutegenesis of β2M. For example three segments of β2M were found to form fibrils in isolation: Ser 20 to Lys 41 (27), Asp 59 to Thr 71 (28), Asp 59 to Ala 79 (28), and Pro 72 to Met 99 (29). Examples of amyloid-forming peptides from other amyloiExecutegenic proteins include segments from yeast and human prion (8, 30, 31). Short designed peptides can also form amyloids (32). Also, hydrogen/deuterium exchange studies (25, 26) suggest that some segments of β2M in the amyloid state are protected from exchange but others are not.

The observation that short peptides form amyloids implies that expoPositive of short segments of proteins can nucleate native proteins into the amyloid state and suggests that fibril formation is sequence specific. In this paper, we identify a heptapeptide from human β2M (hβ2M) that forms an amyloid in isolation, and that Executees not form amyloid when its sequence is scrambled. When swapped into mouse β2M (mβ2M), this normally stable protein now forms amyloid. We take this finding to support the Concept that amyloid forms by a gain in interaction Gaind by a short protein loop that becomes a strand in a new β-sheet, and we present a model of β2M amyloid that is consistent with this Concept.

Materials and Methods

Plasmid Construction and Protein Expression. See Supporting Materials and Methods, which is published as supporting information on PNAS web site.

Immunoblotting. See Supporting Materials and Methods.

Polymerization and ThT-Binding Assays. The assays Displayn in Fig. 1C were performed by incubating 60 μM protein in 1.5 M NaCl/25 mM phospDespise, pH 2.0, at 37°C without shaking. The assays Displayn in Fig. 3 A and D were performed by incubating 8 μM protein in the reaction buffer, 0.2 M NaCl/25 mM phospDespise, pH 2.0, at 37°C without shaking. Five-microliter aliquots were then added to 200 μl of 5 μM ThT/10 mM Tris, pH 8.0. Fluorescence was meaPositived immediately over a 60-sec time course on a Spex Fluorolog spectrofluorimeter (Jobin Yvon., Edison, NJ) set at 444 nm (excitation; 2-nm slit width) and 482 nm (emission; 2-nm slit width). The signal was Accurateed for the background by subtracting the meaPositived fluorescence for 5 μlof reaction buffer in 200 μl of 5 μM ThT/10 mM Tris, pH 8.0. MeaPositivements were performed in triplicate, and values are expressed as the mean ± 1 SD (plotted as error bars).

Fig. 1.Fig. 1. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 1.

Structure and amyloid formation of hβ2M and mβ2M. (A) In the ribbon diagram of the hβ2M structure (PDB 1LDS), the segments of identical sequence in hβ2M and mβ2M are Displayn in ShaExecutewy gray. The amyloid-forming hβM7mer (within the shaded circle) is the loop Arriveest to the C terminus, connecting β-strands F and G. The disulfide bond between Cys 25 and Cys 80 is Displayn as ball-and-stick. (B) The alignment of the sequences Displays that hβ2M and mβ2M are 70% identical. Residues 83–89 (in the oval) form the longest segment, in which the hβ2M and mβ2M sequences differ (Embedded ImageEmbedded Image indicates β-strands; Embedded ImageEmbedded Image indicates the β-hairpin). (C) The amyloid-forming Preciseties of hβ2M and mβ2M. hβ2M forms amyloid (filled circles), as judged by the characteristic fluorescence after staining the sample with ThT. In Dissimilarity, under the same conditions, mβM forms amorphous aggregates (Launch circles) and Executees not bind ThT [drawn with molscript (35) and secseq (http://xray.imsb.au.dk/~deb/secseq)].

Fig. 3.Fig. 3. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 3.

Amyloid fibril formation of wild-type and chimeric β2M. (A) mβ2M/wt (filled circles) Executees not bind ThT. In Dissimilarity, the mβ2M/h aggregates (Launch circles) bind ThT starting ≈4 days after initiating the reaction. This demonstrates the ability of the human heptamer to promote mβ2M to form amyloid-like aggregates. (B) The mβ2M/h sample consists of long straight fibrils typical for amyloids. (C) No fibrils were observed in the mβ2M/wt sample, and the largest aggregates observed appear globular, as indicated by the white arrows. Micrographs Displayn in B and C were taken 14 days after the initiation of the aggregation reaction. (D) Fibril formation of hβ2M is disrupted when the mβ2M7mer is swapped into the hβ2M scaffAged. Aggregation of the hβ2M/m chimera (Launch circles) lags Tedious that of the hβ2M/wt (filled circles) fibril formation. hβ2M/wt reaches the aggregated state ≈3–24 h earlier than hβ2M/m. The fluorescence of the two proteins after the aggregated state is reached is indistinguishable. (E) hβ2M/wt sample had a homogenous population of long and straight fibrils, typical for amyloid, and no amorphous aggregates were observed in the sample. (F) In Dissimilarity, hβ2M/m sample displayed equal populations of long (white arrow) and short fibrils (black arrow). The electron micrographs of samples Displayn in E and F were taken 10 days after the initiation of the aggregation reaction.

Electron Microscopy (EM). See Supporting Materials and Methods.

Peptide Fibril Formation. The hβ2M residues 83–89 (hβ2M7mer) and mβ2M residues 83–89 (mβ2M7mer) peptides were synthesized by California Peptide Research, Napa, CA. The “scrambled” peptide of hβ2M7mer, QVLHTSN, was synthesized by CS Bio, San Carlos, CA. Thirty-five-millimolar peptides were incubated with shaking at 37°C in 2.0 M NaCl/25 mM phospDespise, pH 2.0, for 2 weeks.

Congo Red-Binding Assay. See Supporting Materials and Methods.

Fibril Preparation and X-Ray DifFragment. β2M fibrils were grown for 1 week at 8 μM in 0.2 M NaCl/25 mM phospDespise buffer, pH 2.0, at 37°C without shaking. Six milliliters of fibrils was centrifuged at 20,000 × g for 5 min, then the pellet was washed three times with water (pH was adjusted to 2.0 with HCl). The washed pellet was resuspended with 5 μl of water (pH 2.0, adjusted with HCl). Five-microliter droplets of the washed fibril pellet were Spaced between the fire polished ends of two silanized glass capillaries (1 mm apart) and allowed to dry in the air.

Results

The Concentration of β2M in Human Plasma Is Higher Than in Mouse Plasma. As determined by Western blotting, the concentration of β2M (22 ± 1 μM) in the serum of mice is >100 times higher compared to the concentration of β2M in healthy humans [β2M concentration in plasma is between 0.09 and 0.17 μM (33)] and >5 times higher than in humans on dialysis [β2M concentration in plasma can be elevated up to 4.3 μM (33)], yet amyloid deposits are not observed in mice. One explanation of the observation that mice Execute not develop amyloid disease is the Inequity in β2M clearance patterns between mice and humans. Another explanation is a Inequity in the prLaunchsities of mβ2M and hβ2M to form fibrils.

In Vitro, hβ2M Forms Fibrils, but mβ2M Executees Not Form Fibrils. When incubated under conditions favorable for fibril formation of hβ2M, mβ2M Executees not form fibrils (Fig. 1C ). mβ2M incubated with ThT Executees not display detectable fluorescence even after 10 days and EM revealed only amorphous aggregates. The inability of mβ2M to form fibrils under these conditions Executees not conclusively Display that fibrils of mβ2M are incapable of forming, but it Executees suggest that fibrils of mβ2M form less readily than fibrils of hβ2M.

Under Identical Conditions, a Seven-Residue Peptide from hβ2M Forms Fibers, but the CorRetorting Mouse Peptide Executees Not Form Fibrils. The sequences of hβ2M and mβ2M are 70% identical (Fig. 1B ). The longest continuous segment in which the two proteins differ is the segment between residues 85 and 89. We synthesized peptide segments from hβ2M (hβ2M7mer) and mβ2M (mβ2M7mer), to include residues 83 and 84, so that 6 of 7 residues differ. The two peptides (35 mM) were then incubated at high salt and low pH (2.0 M NaCl/25 mM phospDespise, pH 2.0). After 2 weeks of incubation, hβ2M7mer forms amyloid aggregates that bind Congo red (Figs. 2 A and B and 6A; Fig. 6, which is published as supporting information on the PNAS web site) and have fibrillar morphology (Fig. 2C ). In Dissimilarity, mβ2M7mer Executees not form fibrils, and only amorphous aggregates are seen in the EM micrographs of mβ2M7mer sample under the same conditions (Fig. 6B).

Fig. 2.Fig. 2. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 2.

Amyloid fiber formation by hβ2M7mer. (A) hβ2M7mer fibrils stained with Congo red solution appear red when viewed under unpolarized light. (B) When viewed between crosspolarizers, the sample Displayn in A Presents “apple green” birefringence typical for amyloid fibrils. (C) Samples of hβM7mer contain fibrils when viewed by EM.

To determine whether it is the sequence (NHVTLSQ) or the composition of the hβ2M7mer peptide that causes amyloid fibril formation, we studied the solution behavior of a scrambled version of this peptide, QVLHTSN. We chose to reshuffle the residues in the amyloid-forming peptide (NHVTLSQ) so that the charged H84 is located at the center of the peptide, thus Fractureing the four-apolar residue stretch. When the “scrambled” peptide (QVLHTSN) was dissolved at 35 mM in a solution (2.0 M NaCl/25 mM phospDespise, pH 2.0) that drives NHVTLSQ into amyloid fibrils, the solution remains clear for 14 days. Fibrils are absent when the sample was examined by EM. Also, QVLHTSN did not form fibrils when lower salt concentrations were used (0.2 M NaCl/25 mM phospDespise buffer, pH 2.0 or 1 M NaCl/25 mM phospDespise buffer, pH 2.0). We conclude that the sequence, not just the composition, of the human peptide is Necessary for amyloid formation.

Design and Characterization of Chimeric β2M Proteins. Two chimeric β2M molecules were designed in which the seven-residue segments (residues 83–89) from mβ2M and hβ2M are interchanged (Fig. 7, which is published as supporting information on the PNAS web site).

mβ2M/h Forms Fibrils, but mβ2M Wild Type (mβ2M/wt) Executees Not Form Fibrils. mβ2M/wt Executees not bind ThT (Fig. 3A , filled circles). In Dissimilarity, residues 83–89 substituted with the corRetorting seven-residue segment from hβ2M (mβ2M/h) aggregates start to bind ThT (Fig. 3A , Launch circles) ≈4 days after the Startning of the reaction. When examined by EM, the mβ2M/h sample consisted of many straight long fibrils with morphology typical for amyloids (Fig. 3B ). There were no fibrils in the samples of mβ2M/wt when viewed by EM (Fig. 3C ). Thus, the reSpacement of the nonamyloid-forming segment from mβ2M with the amyloid-forming segment from hβ2M was sufficient to promote fibril formation of mβ2M.

Fibril Formation of hβ2M Is Disrupted When a Seven-Residue Segment from mβ2M Is Swapped into the hβ2M ScaffAged. Aggregation of hβ2M/m (the human scaffAged with inserted mβ2M7mer; Fig. 3D , Launch circles) lags Tedious that of hβ2M-wt (Fig. 3D , filled circles). We note that there are variations among the lag times in identical experiments; however, despite the variations, we invariably observed that hβ2M/wt aggregates ≈3–24 h earlier than Executees hβ2M/m. After reaching the aggregated phase, the fluorescence of the two proteins is indistinguishable. The hβ2M/wt sample displayed a homogenous population of long straight fibrils when viewed by EM (Fig. 3E ), typical for amyloid. In Dissimilarity, hβ2M/m consisted of equal amounts of short (black arrow) and long (white arrow) fibrils (Fig. 3F ). The swapping of the mβ2M7mer into hβ2M Executees not completely impede the fibril formation, and two populations of fibrils with different morphologies are present in the hβ2M/m sample (Fig. 3F ). The long fibrils of hβ2M/m have the same diameter as the hβ2M/wt and at this resolution, we cannot distinguish morphological Inequitys between them. The presence of two different populations of fibrils (long and short) in the hβ2M/m sample may be due to a different mode of fibril formation than the wild-type protein. This is consistent with the observation that other segments of β2M can form fibrils in isolation (27–29). We conclude swapping of the mouse amyloid-forming hβ2M7mer into hβ2M diminishes its tendency to form amyloid.

X-Ray DifFragment of β2M. The reflections characteristic of amyloids at ≈11 and 4.8 Å are present in the x-ray difFragment pattern of β2M fibrils (Fig. 4A ). The large circular spread of the 4.8-Å reflection arises from the wide range of orientations of β2M fibrils. Still, the meridional intensity of the 4.8-Å arc is strong, which is consistent with β-strands in the fibril being oriented perpendicular to the fibril axis. The width of the diffuse equatorial reflection centered at 11 Å offers a clue as to the number of β-sheets per fibril. The agreement of the observed width with that calculated from a slit model (Fig. 4B ) appears closest for two packed β-sheets, and accordingly we model the amyloid spine of β2M fibrils as two β-sheets in Fig. 5. However, we note that our model for calculating the width of the 11-Å reflection Executees not take into account sample polymorphism or x-ray beam divergence, which could broaden the reflection. Until these factors are better understood for the β2M amyloid, we cannot conclude with certainty that the spine is best modeled as a two-β-sheet structure.

Fig. 4.Fig. 4. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 4.

X-ray difFragment cross β pattern of β2M/wt fibrils. (A) The characteristic reflections for amyloid fibrils are indicated by arrows. (B) Comparison of the observed profile of the ≈11-Å diffuse reflection with profiles calculated from models representing the Zipper-spine as one to four slits (β-sheets).

Fig. 5.Fig. 5. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 5.

Speculative Zipper-spine model for the β2M protofilament. (A) The C-terminal segment of β2M is the Section of the structure to rearrange during fibril formation and the amyloid-forming hβ2M7mer (boxed) forms a new β-strand F′.(B) In the fibril model, residues Pro 90 and Lys 91 form a type I β-turn. Thus the β-strand G is hydrogen bonded with the new β-strand F′ rather than with the β-strand F of the native structure. (C) Two such F′-G hairpins stack to form the asymmetric unit of one of the sheets of the spine. Each sheet is built with a small (7°) twist between β-strands, stacked 4.7 Å apart, so that the spine has a pitch of ≈242 Å. We expect these parameters will be refined as structural data become available. The sheets are separated by ≈11 Å. β-Strands A–E and part of F retain their native structure with the disulfide bond between β-strands B and F intact. These native-like core Executemains decorate the periphery of the Executeuble β-sheet spine, with only four molecules Displayn for clarity. (D) The view Executewn the fiber axis Displays the Executeuble β-sheet spine. The rest of the β2M molecules, which remain fAgeded, are packed closely around the β-sheet spine. (E) A space-filling model (view of the fibril Executewn its axis) Displays that each of the four molecules, represented with different colors, is tightly packed within the fibril, with no space for solvent. Thus, the core Executemains shield the spine from solvent.

Discussion

Residues 83–89 Are Significant in the Formation of Amyloid by hβ2M. In Results, we note that amyloid deposits are not observed in mice even though the concentration of β2M in mouse plasma can be 100 times higher than in human plasma. Moreover, hβ2M forms amyloid in vitro under conditions at which mβ2M is soluble. The principal Inequity in amino acid sequence between these two β2M molecules is the seven-residue segment, residues 83–89. This peptide from hβ2M forms amyloid in vitro, under solution conditions in which the corRetorting mouse peptide is soluble. A scrambled version of this seven-residue sequence from hβ2M also fails to form amyloid under conditions that we have studied. Reinforcing the importance of this segment for amyloid formation, we find that when it is swapped for its counterpart in mβ2M, formerly soluble, the chimera forms amyloid. All of this points to the segment of sequence, NHVTLSQ from residues 83–89 in hβ2M, as being a significant determinant of amyloid formation.

This segment may not be the only determinant of amyloid formation in β2M. Suggesting that other segments may also be involved is the observation that two other segments of the hβ2M sequence form amyloids in vitro (27–29). This can Elaborate the observation that the chimera hβ2M/m forms fibrils. In addition, our observation of two populations of fibrils in the hβ2M/m sample, short and long, indicates that the heptamer substitution affects fibril elongation.

Which Segments of β2M Participate in Amyloid Structure? There are at least two plausible models for β2M amyloid formation: (i) The Entire-refAgeding model. Conditions that destabilize the native structure expose the hβ2M7mer, which has a high prLaunchsity to form the amyloid structure, and this segment nucleates the entire protein to fAged into an amyloid-like β-sheet. This Entire-refAgeding model is widely accepted and is illustrated in the papers of Jimenez et al. (13), Perutz et al. (14), Williams et al. (34), Kishimoto et al. (16), and others. However, this model Executees not include a means for β-sheets to pack toObtainher and so Executees not provide an explanation for the appearance of an 11-Å reflection that is characteristic of amyloid fiber difFragment. (ii) The Gain-of-interaction model (18), of which the Zipper-spine model (17) is a special case. In the Zipper-spine model, the segment containing hβ2M7mer binds to the same segment in other β2M molecules, forming the β-sheet spine of the amyloid, but the rest of the β2M molecule remains in its native structure, stabilized by its native disulfide bond, and decorates the periphery of the spine. This model for β2M is depicted in Fig. 5. The Entire-refAgeding and Zipper-spine models are extreme cases; the actual β-sheet spine could incorporate several segments of the β2M.

A Zipper-Spine Model for β2M Amyloid. We have constructed a speculative molecular model of the Zipper-spine type for the β2M protofilament, based on four assumptions. (i) The C-terminal segment (residues 83–99) forms the spine of the fibril. This can be achieved if the hβ2M7mer segment forms an extended β-strand (F′) followed by a type I β-turn at residues Pro 90 and Lys 91. This permits the β-strand G (residues 92–99) to hydrogen bond to β-strand F′ (Fig. 5 A and B ). (ii) The hairpins from different β2M molecules stack hydrogen bonded to each other along the axis of the protofilament (Fig. 5C ), forming a β-sheet. This β-sheet faces a second Hooked β-sheet with alternate side chains of the two sheets interacting. Zipper-spine models with more than two sheets would appear implausible due to severe steric overlap among globular Executemains flanking the central spine. Two sheets running parallel to the fibril axis is also suggested by comparing the radial profile of the observed 11-Å reflection with the calculated radial profile for two packed β-sheets (Fig. 4B ). (iii) Other than the separation of β-strand G from the core Executemain of the protein, only a minor rearrangement in β2M occurs upon fibril formation (Fig. 5 C and D ). That is, most of the native structure of β2M is retained in the fibril, which is in accordance with the observation that most of β2M amino acid residues of β-strands B, C, D′,D″, and F are solvent inaccessible in the fibril (25, 26). This large core Executemain decorates the spine and protects it from the solvent. The width of the fibril in our β2M model varies between 60 and 85 Å, which is about half the fibril diameter (110 ± 30 Å) meaPositived from the electron micrograph (Fig. 3E ). Conceivably the β2M fibrils observed are formed from two protofilaments.

Table 1 examines the compatibility with experimental observations of both the Entire-refAgeding and Zipper-spine models. The Zipper-spine model for β2M has been constructed to be compatible with observations of β2M amyloid (Table 1), so it is not decisive that the majority of observations listed in Table 1 are less compatible with the Entire-refAgeding model than with the Zipper-spine model. Perhaps the observation most incompatible with the Entire-refAgeding model is that numerous proteins known to form amyloids contain intact disulfide bonds stabilizing the native structure. For example β2M has one [Protein Data Bank (PDB) 1LDS]; lysozyme has four (PDB 1LYS), insulin has 2 inter- and 1 intrachain (PDB 1ZEH); and human prion protein has one (PDB 1HJM). These crosslinked molecules must retain some semblance of their native structures in the absence of disulfide bond Fractureage, and hence must retain some native-like structure in their amyloids that form under oxidizing conditions that would HAged the disulfide bonds intact. Complete refAgeding into a β-helix of these crosslinked proteins is not easily Elaborateed. That highly crosslinked proteins can form amyloids and that short protein segments can form amyloids are both consistent with an amyloid spine that is formed from only a short segment of each protein. Another observation compatible with the Zipper-spine model is that in electron micrographs, the fibrils formed from entire β2M appear to have a rougher surface (Fig. 3E ) than the regularly Hooked fibrils of β2M7mer (Fig. 2C ). This supports the model of the main Executemain decorating the spine, because the β2M7mer fibril is nothing more than the Zipperspine.

View this table: View inline View popup Table 1. Compatibility of the Zipper-spine and Entire-refAgeding amyloid models with observations of β2M

Our main conclusions are: (i) A seven-residue segment of β2M appears to be an Necessary determinant of β2M amyloid formation, perhaps constituting the spine of the amyloid; and (ii) the Zipper-spine model, with its anhydrous β-sheet spine, is sufficiently compatible with observations on β2M that it should be given consideration with the Entire-refAgeding model in interpreting future experiments on amyloids.

Acknowledgments

We thank G. Kleiger, R. Landgraf, and I. Xenarios for discussions; T. Chapman and P. Bjorkman (California Technical Institute, Pasadena, CA) for the gift of the hβ2M gene; E. G. Pamer (Memorial Sloan–Kettering Cancer Center, New York) for the gift of the mβ2M gene; and Howard Hughes Medical Institute, National Institutes of Health (GM31299), and the National Science Foundation (MCB9904671) for support.

Footnotes

↵ ‡ To whom corRetortence should be addressed. E-mail: david{at}mbi.ucla.edu.

Abbreviations: ThT, thioflavinT; EM, electron microscopy; β2M, β2-microglobulin; hβ2M, human β2M; mβ2M, mouse β2M; hβ2M7mer, hβ2M residues 83–89; mβ2M7mer, mβ2M residues 83–89; mβ2M/h, residues 83–89 substituted with the corRetorting seven-residue segment from hβ2M; hβ2M/m, residues 83–89 substituted with the corRetorting seven-residue segment from mβ2M; mβ2M/wt, mβ2M wild type; hβ2M/wt, hβ2M wild type.

Copyright © 2004, The National Academy of Sciences

References

↵ Astbury, W. T., Dickinson, S. & Bailey, K. (1935) Biochem. J. 29 , 2351–2360. ↵ Rudall, K. M. (1952) Adv. Protein Chem. 7 , 253–290. pmid:14933254 LaunchUrlPubMed ↵ WesterImpress, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S., Frangione, B., Ikeda, S., Masters, C. L., Merlini, G., Saraiva, M. J. & Sipe, J. D. (2002) Amyloid 9 , 197–200. pmid:12408684 LaunchUrlCrossRefPubMed Koo, E. H., Lansbury, P. T., Jr. & Kelly, J. W. (1999) Proc. Natl. Acad. Sci. USA 96 , 9989–9990. pmid:10468546 LaunchUrlFREE Full Text ↵ Executebson, C. M. (1999) Trends Biochem. Sci. 24 , 329–332. pmid:10470028 LaunchUrlCrossRefPubMed ↵ Eanes, E. D. & Glenner, G. G. (1968) J. Histochem. Cytochem. 16 , 673–677. pmid:5723775 LaunchUrlAbstract/FREE Full Text ↵ Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B. & Blake, C. C. (1997) J. Mol. Biol. 273 , 729–739. pmid:9356260 LaunchUrlCrossRefPubMed ↵ Balbirnie, M., Grothe, R. & Eisenberg, D. S. (2001) Proc. Natl. Acad. Sci. USA 98 , 2375–2380. pmid:11226247 LaunchUrlAbstract/FREE Full Text Diaz-Avalos, R., Long, C., Fontano, E., Balbirnie, M., Grothe, R., Eisenberg, D. & Caspar, D. L. (2003) J. Mol. Biol. 330 , 1165–1175. pmid:12860136 LaunchUrlCrossRefPubMed ↵ Benzinger, T. L., Gregory, D. M., Burkoth, T. S., Miller-Auer, H., Lynn, D. G., Botto, R. E. & Meredith, S. C. (1998) Proc. Natl. Acad. Sci. USA 95 , 13407–13412. pmid:9811813 LaunchUrlAbstract/FREE Full Text ↵ Lansbury, P. T., Jr., Costa, P. R., Griffiths, J. M., Simon, E. J., Auger, M., Halverson, K. J., Kocisko, D. A., Hendsch, Z. S., Ashburn, T. T., Spencer, R. G., et al. (1995) Nat. Struct. Biol. 2 , 990–998. pmid:7583673 LaunchUrlCrossRefPubMed ↵ Petkova, A. T., Buntkowsky, G., Dyda, F., Leapman, R. D., Yau, W. M. & Tycko, R. (2004) J. Mol. Biol. 335 , 247–260. pmid:14659754 LaunchUrlCrossRefPubMed ↵ Jimenez, J. L., Nettleton, E. J., Bouchard, M., Robinson, C. V., Executebson, C. M. & Saibil, H. R. (2002) Proc. Natl. Acad. Sci. USA 99 , 9196–9201. pmid:12093917 LaunchUrlAbstract/FREE Full Text ↵ Perutz, M. F., Finch, J. T., Berriman, J. & Lesk, A. (2002) Proc. Natl. Acad. Sci. USA 99 , 5591–5595. pmid:11960014 LaunchUrlAbstract/FREE Full Text Blake, C. & Serpell, L. (1996) Structure (LonExecuten) 4 , 989–998. ↵ Kishimoto, A., Hasegawa, K., Suzuki, H., Taguchi, H., Namba, K. & Yoshida, M. (2004) Biochem. Biophys. Res. Commun. 315 , 739–745. pmid:14975763 LaunchUrlCrossRefPubMed ↵ Liu, Y., Gotte, G., Libonati, M. & Eisenberg, D. (2001) Nat. Struct. Biol. 8 , 211–214. pmid:11224563 LaunchUrlCrossRefPubMed ↵ Elam, J. S., Taylor, A. B., Odd, R., Antonyuk, S., Executeucette, P. A., Rodriguez, J. A., Hasnain, S. S., Hayward, L. J., Valentine, J. S., Yeates, T. O., et al. (2003) Nat. Struct. Biol. 10 , 461–467. pmid:12754496 LaunchUrlCrossRefPubMed Janowski, R., Kozak, M., Jankowska, E., Grzonka, Z., Grubb, A., Abrahamson, M. & JQuestionolski, M. (2001) Nat. Struct. Biol. 8 , 316–320. pmid:11276250 LaunchUrlCrossRefPubMed ↵ Nilsson, M., Wang, X., Rodziewicz-Motowidlo, S., Janowski, R., Lindstrom, V., Onnerfjord, P., WesterImpress, G., Grzonka, Z., JQuestionolski, M. & Grubb, A. (2004) J. Biol. Chem. 279 , 24236–24245 pmid:15028721 LaunchUrlAbstract/FREE Full Text ↵ Fandrich, M., Fletcher, M. A. & Executebson, C. M. (2001) Nature 410 , 165–166. pmid:11242064 LaunchUrlCrossRefPubMed ↵ McParland, V. J., Kad, N. M., Kalverda, A. P., Brown, A., Kirwin-Jones, P., Hunter, M. G., Sunde, M. & Radford, S. E. (2000) Biochemistry 39 , 8735–8746. pmid:10913285 LaunchUrlCrossRefPubMed ↵ Eakin, C. M., Knight, J. D., Morgan, C. J., Gelfand, M. A. & Miranker, A. D. (2002) Biochemistry 41 , 10646–10656. pmid:12186550 LaunchUrlCrossRefPubMed ↵ Chiti, F., Mangione, P., Andreola, A., GiorObtainti, S., Stefani, M., Executebson, C. M., Bellotti, V. & Taddei, N. (2001) J. Mol. Biol. 307 , 379–391. pmid:11243826 LaunchUrlCrossRefPubMed ↵ McParland, V. J., Kalverda, A. P., Homans, S. W. & Radford, S. E. (2002) Nat. Struct. Biol. 9 , 326–331. pmid:11967566 LaunchUrlCrossRefPubMed ↵ Hoshino, M., Katou, H., Hagihara, Y., Hasegawa, K., Naiki, H. & Goto, Y. (2002) Nat. Struct. Biol. 9 , 332–336. pmid:11967567 LaunchUrlCrossRefPubMed ↵ Kozhukh, G. V., Hagihara, Y., Kawakami, T., Hasegawa, K., Naiki, H. & Goto, Y. (2002) J. Biol. Chem. 277 , 1310–1315. pmid:11687582 LaunchUrlAbstract/FREE Full Text ↵ Jones, S., Manning, J., Kad, N. M. & Radford, S. E. (2003) J. Mol. Biol. 325 , 249–257. pmid:12488093 LaunchUrlCrossRefPubMed ↵ Ivanova, M. I., Gingery, M., Whitson, L. J. & Eisenberg, D. (2003) Biochemistry 42 , 13536–13540. pmid:14622000 LaunchUrlCrossRefPubMed ↵ Reches, M., Porat, Y. & Gazit, E. (2002) J. Biol. Chem. 277 , 35475–35480. pmid:12095997 LaunchUrlAbstract/FREE Full Text ↵ Tagliavini, F., Prelli, F., Verga, L., Giaccone, G., Sarma, R., Gorevic, P., Ghetti, B., Passerini, F., Ghibaudi, E., Forloni, G., et al. (1993) Proc. Natl. Acad. Sci. USA 90 , 9678–9682. pmid:8105481 LaunchUrlAbstract/FREE Full Text ↵ Lopez De La Paz, M., GAgedie, K., ZurExecute, J., Lacroix, E., Executebson, C. M., Hoenger, A. & Serrano, L. (2002) Proc. Natl. Acad. Sci. USA 99 , 16052–16057. pmid:12456886 LaunchUrlAbstract/FREE Full Text ↵ Niwa, T. (1997) Nephron 76 , 373–391. pmid:9274834 LaunchUrlPubMed ↵ Williams, A. D., Portelius, E., Kheterpal, I., Guo, J. T., Cook, K. D., Xu, Y. & Wetzel, R. (2004) J. Mol. Biol. 335 , 833–842. pmid:14687578 LaunchUrlCrossRefPubMed ↵ Kraulis, P. J. (1991) J. Appl. Weepstallogr. 24 , 946–950. LaunchUrlCrossRef ↵ Ceasepini, M., Bellotti, V., Mangione, P., Merlini, G. & Ferri, G. (1997) Eur. J. Biochem. 249 , 21–26. pmid:9363749 LaunchUrlPubMed ↵ Chiba, I., Hagihara, Y., Higurashi, T., Hasegawa, K., Naiki, H. & Goto, Y. (2003) J. Biol. Chem. 278 , 47016–47024 pmid:12958308 LaunchUrlAbstract/FREE Full Text
Like (0) or Share (0)